Novo Nordisk

Novo Impressed Wall Street with Its 1Q16 Earnings
Yahoo/Market Realist
Mon, 05/2/16 - 10:03 pm
Novo Nordisk
earnings
Germany Is New Battlefield for Drugmakers Facing Price Scrutiny
Bloomberg
Mon, 04/25/16 - 08:07 am
Germany
drug pricing
Roche
Bayer
Novo Nordisk
Novo Nordisk: 'Holy Grail' Diabetes Pill Has Big Advantages
Seeking Alpha
Wed, 04/20/16 - 09:50 am
Novo Nordisk
diabetes
Victoza
Victoza to Fuel Growth for Novo Nordisk
Yahoo/Market Realist
Sat, 04/16/16 - 04:08 pm
Novo Nordisk
Victoza
diabetes
How Is Novo Nordisk Doing in the Diabetes Space?
Yahoo/Market Realist
Tue, 04/12/16 - 08:32 am
Novo Nordisk
diabetes
Orexigen: Contrave Sales Flatten Out At End Of Q1
Seeking Alpha
Mon, 04/11/16 - 09:58 am
Orexigen
Contrave
obesity
Novo Nordisk
Vivus
Arena Pharmaceuticals
Novo makes inroads in Japan with long-acting insulin Tresiba
Fierce Pharma
Fri, 04/8/16 - 09:54 pm
Japan
Novo Nordisk
diabetes
insulin
Tresiba
Insulin prices have skyrocketed, putting drug makers on the defensive
Stat
Wed, 04/6/16 - 09:56 am
insulin
diabetes
drug pricing
Eli Lilly
Novo Nordisk
Medicare
Why Did Novo’s Share Price Fall after Fiscal 2015 Earnings?
Yahoo/Market Realist
Thu, 03/31/16 - 09:27 pm
Novo Nordisk
earnings
Novo Nordisk gives hiring update on 700 jobs pledge, breaks ground on Clayton facility
Bizjournals.com
Mon, 03/28/16 - 06:53 pm
hirings
Novo Nordisk
drug manufacturing
Why ViiV Healthcare leads the pharma industry in corporate reputation
BioPharma Dive
Wed, 03/23/16 - 04:23 pm
ViiV Healthcare
Pfizer
GSK
Shionogi
AbbVie
Lundbeck
Janssen
Novo Nordisk
Novo Nordisk Follows Eli Lilly as Worthy Rival to Merck in Diabetes
Bidness, ETC
Tue, 03/8/16 - 10:14 am
Novo Nordisk
Eli Lilly
Merck
diabetes
Victoza
Express Scripts unimpressed by insulin data on Novo's Tresiba
BioPharma Dive
Thu, 03/3/16 - 10:41 am
Express Scripts
insulin
Novo Nordisk
diabetes
Tresiba
Lantus
Novo Nordisk notches another phase 3 success for GLP-1 drug
BioPharma Dive
Fri, 02/26/16 - 10:18 am
Novo Nordisk
diabetes
GLP-1 agonist
semaglutide
Novo Nordisk's weekly diabetes drug goes 5-for-5 in Phase III
Fierce Biotech
Thu, 02/25/16 - 09:58 am
diabetes
Novo Nordisk
semaglutide
How Much Does Novo Spend on Its Pipeline?
Yahoo/Market Realist
Tue, 02/23/16 - 05:49 pm
Novo Nordisk
FDA sets LixiLan decision date for Sanofi-Novo diabetes showdown; Eylea could outshine Bayer's sales forecasts, analyst predicts
Fierce Pharma
Mon, 02/22/16 - 06:08 pm
FDA
LixiLan
Sanofi
Novo Nordisk
Bayer
Eylea
How Tresiba and Xultophy Will Drive Novo’s Performance
Yahoo/Market Realist
Fri, 02/19/16 - 10:13 am
Novo Nordisk
Tresiba
Xultophy
earnings
Why Novo Nordisk Fell after Its 4Q15 Earnings Release
Yahoo/Market Realist
Tue, 02/9/16 - 09:15 am
Novo Nordisk
earnings
How Novo’s Diabetes and Obesity Care Segment Performed in 4Q15
Yahoo/Market Realist
Mon, 02/8/16 - 09:29 pm
Novo Nordisk
obesity
diabetes
earnings

Pages